Zoetis Inc. (NYSE:ZTS) was one of the stocks on which Jim Cramer shared his take, explaining that dot-com analogies do not ...

Zoetis Inc. (NYSE:ZTS) is one of the best NYSE stocks to buy according to Wall Street analysts. On May 7, Zoetis reported Q1 ...

Zoetis faces renewed scrutiny after earnings miss and guidance reset, reshaping its outlook within healthcare and broader ...

Zoetis reported first-quarter earnings on Thursday, and the market did not like what it saw.

Zoetis faced a challenging first quarter of 2026 as its results missed Wall Street’s expectations, prompting a significant ...

(Reuters) -Zoetis raised annual forecast and beat second-quarter estimates on Tuesday, driven by strong demand for its medicines and vaccines for pets, sending the animal healthcare company's shares ...

Zoetis continues attracting attention after its latest earnings update highlighted animal health expansion, global market ...

The animal-health company missed first-quarter earnings estimates.

PARSIPPANY, N.J.--(BUSINESS WIRE)--Zoetis Inc.(NYSE: ZTS) today reported its financial results for the second quarter of 2022 and updated its guidance for full year 2022 to reflect its positive ...

Zoetis (ZTS) faces significant competitive and pricing headwinds, with shares down 37% YTD and trading at a five-year low.

Zoetis (ZTS) stock drops as the company lowers its financial guidance after lower-than-expected Q1 2026 earnings driven by ...

The Commerce Commission has received a clearance application from Zoetis Holdings LLC to acquire the global animal genomic testing business of Neogen Corporation. In New Zealand, both Zoetis and ...